INHIBITION OF THROMBIN-INDUCED AND COLLAGEN-INDUCED PHOSPHOINOSITIDES BREAKDOWN IN RABBIT PLATELETS BY A PAF ANTAGONIST DENUDATIN-B, AN ISOMER OF KADSURENONE

被引:13
作者
TENG, CM [1 ]
YU, SM [1 ]
CHEN, CC [1 ]
HUANG, YL [1 ]
HUANG, TF [1 ]
机构
[1] NATL RES INST CHINESE MED,TAIPEI,TAIWAN
关键词
Denudatin B; Magnolia fargesii; PAF antagonists; Phosphoinositides breakdown; Rabbit platelets; Thromboxane B[!sub]2[!/sub] formation;
D O I
10.1016/0049-3848(90)90277-J
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Denudatin B, an isomer of kadsurenone, was isolated from Magnolia fargesii. It inhibited the aggregation and ATP release of washed rabbit platelets caused by platelet-activating factor (PAF) in a concentration-dependent manner. The IC50 on PAF (2 ng/ml)-induced aggregation was about 10 μg/ml. High concentration of denudatin B (>50 μg/ml) also inhibited the aggregation and ATP release of platelets caused by ADP, collagen, arachidonic acid and thrombin. However, shape change of platelets still existed. Prolongation of the incubation time with platelets could not cause further inhibition, and the aggregability of platelets could be restored after denudatin B was washed out from platelets. Thrombin-induced thromboxane B2 formation was almost completely suppressed. In the absence of extracellular calcium (EGTA 1 mM), ATP release caused by thrombin was inhibited. Thrombin-induced rise of the intracellular calcium concentration was suppressed by denudatin B, but not by BN52021 or kadsurenone. The generation of inositol phosphate in washed platelets caused by collagen, PAF and thrombin was also suppressed. The data indicate that PAF antagonist denudatin B has nonspecific antiplatelet action at high concentration by inhibiting phosphoinositides breakdown induced by collagen and thrombin. © 1990.
引用
收藏
页码:121 / 130
页数:10
相关论文
共 23 条
  • [1] BRAQUET P, 1987, PHARMACOL REV, V39, P97
  • [2] PAF-ACETHER SPECIFIC BINDING-SITES .2. DESIGN OF SPECIFIC ANTAGONISTS
    BRAQUET, P
    GODFROID, JJ
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, 7 (10) : 397 - 403
  • [3] CAZENAVE JP, 1979, LAB INVEST, V41, P275
  • [4] CHANG HM, 1986, PHARM APPLICATIONS C, P629
  • [5] CHEN CC, 1988, CHEM PHARM BULL, V36, P1791
  • [6] CHESNEY CM, 1982, BLOOD, V59, P582
  • [7] DeLuca M., 1978, METHOD ENZYMOL, V57, P3, DOI DOI 10.1016/0076-6879(78)57003-1
  • [8] ETIENNE A, 1988, GINKGOLIDES CHEM BIO, P115
  • [9] THE EFFECTS OF LITHIUM ON PLATELET PHOSPHOINOSITIDE METABOLISM
    HUANG, EM
    DETWILER, TC
    [J]. BIOCHEMICAL JOURNAL, 1986, 236 (03) : 895 - 901
  • [10] HUMAN-PLATELET STIMULATION BY ACETYL GLYCERYL ETHER PHOSPHORYLCHOLINE
    MCMANUS, LM
    HANAHAN, DJ
    PINCKARD, RN
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1981, 67 (03) : 903 - 906